ProfileGDS4718 / 226425_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 38% 47% 96% 32% 60% 17% 27% 38% 53% 41% 49% 59% 27% 18% 24% 59% 51% 25% 11% 38% 44% 53% 52% 52% 47% 39% 56% 23% 42% 16% 24% 68% 48% 42% 64% 41% 21% 66% 42% 96% 49% 20% 65% 29% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.9037738
GSM549102patient 115, normal, homogenized [OPG study]5.3703247
GSM549104patient 119, normal, homogenized [OPG study]10.712896
GSM549108patient 138, normal, homogenized [OPG study]4.657832
GSM549119patient 077, normal, homogenized [OPG study]6.1067160
GSM549133patient 032, cancer, homogenized [OPG study]4.0029617
GSM549139patient 042, cancer, homogenized [OPG study]4.3833227
GSM549099patient 107, normal, homogenized [OPG study]4.9159538
GSM549109patient 139, normal, homogenized [OPG study]5.6941353
GSM549110patient 046, normal, homogenized [OPG study]5.0270841
GSM549114patient 063, normal, homogenized [OPG study]5.4328649
GSM549122patient 082, normal, homogenized [OPG study]6.0934359
GSM549134patient 033, cancer, homogenized [OPG study]4.4034827
GSM549136patient 036, cancer, homogenized [OPG study]4.0069418
GSM549140patient 044, cancer, homogenized [OPG study]4.241724
GSM549111patient 047, normal, homogenized [OPG study]6.0283759
GSM549113patient 057, normal, homogenized [OPG study]5.5061151
GSM549132patient 031, cancer, homogenized [OPG study]4.3105225
GSM549137patient 038, cancer, homogenized [OPG study]3.7948311
GSM549142patient 047, cancer, homogenized [OPG study]4.9972838
GSM549100patient 110, normal, homogenized [OPG study]5.2402944
GSM549107patient 135, normal, homogenized [OPG study]5.6771353
GSM549115patient 068, normal, homogenized [OPG study]5.5902552
GSM549116patient 072, normal, homogenized [OPG study]5.5900252
GSM549120patient 078, normal, homogenized [OPG study]5.3453747
GSM549131patient 030, cancer, homogenized [OPG study]4.8660939
GSM549118patient 074, normal, homogenized [OPG study]5.8906756
GSM549129patient 027, cancer, homogenized [OPG study]4.2914823
GSM549123patient 088, normal, homogenized [OPG study]5.0483442
GSM549124patient 006, cancer, homogenized [OPG study]4.048516
GSM549126patient 015, cancer, homogenized [OPG study]4.269724
GSM549128patient 025, cancer, homogenized [OPG study]6.7421868
GSM549103patient 117, normal, homogenized [OPG study]5.4821948
GSM549117patient 073, normal, homogenized [OPG study]5.0672442
GSM549138patient 041, cancer, homogenized [OPG study]6.4216164
GSM549141patient 045, cancer, homogenized [OPG study]4.9852241
GSM549130patient 028, cancer, homogenized [OPG study]4.2155721
GSM549101patient 111, normal, homogenized [OPG study]6.5403366
GSM549105patient 128, normal, homogenized [OPG study]5.120842
GSM549106patient 134, normal, homogenized [OPG study]10.779196
GSM549112patient 048, normal, homogenized [OPG study]5.4252249
GSM549125patient 011, cancer, homogenized [OPG study]4.1543420
GSM549127patient 024, cancer, homogenized [OPG study]6.555665
GSM549135patient 035, cancer, homogenized [OPG study]4.4538629